Business Wire

DNP Develops Recyclable Paper High Barrier Mono-material Sheet for Packaging, as well as other Industrial Applications

Share

Dai Nippon Printing Co., Ltd. (DNP) (TOKYO:7912) has developed an easy to recycle paper monomaterial eco-friendly packaging sheet with high barrier properties. The new product will be introduced at TOKYO PACK 2022 to be held at Tokyo Big Sight from October 12 to 14, 2022.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220912005993/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Packaging utilizing high barrier paper mono-material sheet (Photo: Business Wire)

Background

Decarbonization efforts and ESG investment are accelerating, and packaging suppliers are focused on reducing their environmental impact by developing plant-derived, bio-degradable plastic products. DNP offers Eco-Friendly Packaging*1, including highly recyclable mono-materials, and by using paper instead of petroleum-derived plastic film, the new product will reduce CO2 emissions and contribute to the realization of a recycling-oriented society.

Features

  • Achieving high barrier properties in paper
    DNP has been leveraging its proprietary converting technology*2 to integrate barrier properties in paper materials. Special paper is not necessary and general craft paper can be used. We have also improved resistance to bending and minimized the impairment of barrier properties following bending.
  • Improving recyclability and conductivity
    No metal materials are used in the high barrier coating layer, which is composed of paper mono-material that enhances recyclability. This high barrier paper consists of a thin layer of transparent material that does not affect the transmission of radio waves, and can be used with RFID applications.
  • Its heat-sealability will be useful for packaging applications
    The new product also maintains a heat-seal layer that can be sealed by heat welding.

Going forward

We aim to commercialize the monomaterial sheet for packaging materials used with food, cosmetics, and medical products, and expand our line-up of enhanced barrier properties.

*For further information; https://www.dnp.co.jp/eng/news/detail/20167616_2453.html

1: Eco-Friendly Packaging; https://www.dnp.co.jp/eng/biz/solution/products/materials_package.html

2: Converting technology is a processing technology that transforms and combines materials.

About DNP

DNP was established in 1876, and has become a leading global company that leverages print-based solutions and the strengths of its growing number of partners to engineer fresh business opportunities while protecting the environment and creating a more vibrant world for all. Today we develop and refine technologies for conducting electricity, controlling light and heat, decorating surfaces, and protecting content, effectively becoming a standard-setter for the industry of the future.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media contact
DNP: Yusuke Kitagawa, 81-3-6735-0101 kitagawa-y3@mail.dnp.co.jp

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

The LYCRA Company Announces Collaboration With Qore ® to Use QIRA ® for Next Generation Bio-derived LYCRA ® Fiber at Scale29.9.2022 02:00:00 CEST | Press release

The LYCRA Company,a global leader in developing innovative fiber and technology solutions for the textile and apparel industry, today announced it has entered into an agreement with Qore® to enable the world’s first large-scale commercial production of bio-derived spandex using QIRA®, the next generation 1,4-butanediol (BDO), as one of its main ingredients. This will result in 70% of the LYCRA® fiber content being derived from annually renewable feedstock. This change could potentially reduce the carbon footprint of LYCRA® fiber by up to 44%* versus equivalent product made from fossil-based resources, while maintaining the same high-quality performance parameters of traditional LYCRA® fiber. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220928005020/en/ The LYCRA Company signs an agreement with Qore® LLC to enable large-scale production of bio-derived spandex. Pictured – Julien Born, CEO of The LYCRA Company (left), and Jon

Mainstay Medical Announces Publication of Three-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation ™28.9.2022 22:30:00 CEST | Press release

Mainstay Medical Holdings plc today announced the publication of the three-year patient outcomes data from its pivotal ReActiv8-B clinical trial. The data, published in the journal of the International Neuromodulation Society, Neuromodulation,further establish the efficacy and safety of ReActiv8 Restorative Neurostimulation, including compelling long-term durability and improvement over time on key outcome measures in the treatment of intractable chronic low back pain. The three-year data show improvements over results from the patients’ one-year and two-year visits on virtually all key efficacy measures. Of note: Outcome measure 1-year result (N = 176) 2-year result (N = 156) 3-year result (N = 133) Patients reporting pain intensity (Visual Analog Scale (VAS) score) reduced by 50% or more from baseline 64% 71% 77% Patients reporting a greater than 20-point reduction in Oswestry Disability Index 57% 61% 63% Patients reporting VAS score < 2.5 52% 65% 67% Patients taking opioids at basel

New Study From Egon Zehnder and Kearney Debunks the Myth of a Workplace Generational Divide28.9.2022 16:00:00 CEST | Press release

Egon Zehnder, the world’s preeminent leadership advisory firm, in partnership with Kearney, a leading global management consulting firm, today released findings from a new survey with over 8,000 respondents from eight different countries dismissing the myth of a generation divide in the workplace and showing that despite what is often believed, Gen Z, Millennials, Gen X and Boomers are more alike than different when it comes to workplace matters. The survey, titled “Different Generations, Same Ideals: What Workers of All Ages Value in their Jobs,” analyzed the similarities and differences among generations and found that they share more commonalities, especially when it comes to personal well-being, work-life balance, and desired traits from leadership. The most notable difference between the generations is how each group defines and plans to achieve their career desires. Key Findings from the survey include: Personal well-being, stability, and work-life balance matter more than money

BYD Announces Pre-sale Prices of European Passenger Car Range28.9.2022 15:35:00 CEST | Press release

BYD announces the pre-sale prices of its new European passenger car range. The world’s leading manufacturer of new energy vehicles and power batteries immediately introduces three full-electric passenger vehicles which will be delivered to Norway, Sweden, Denmark, the Netherlands, Belgium, Luxembourg and Germany. Before the end of the year customers in France and the United Kingdom will also have access to BYD’s zero-emission vehicles. After that, more dealers will be appointed supporting BYD’s plans to cover all major markets in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220928005587/en/ BYD Europe Product Premiere 2022 The pre-sale price for the BYD ATTO 3 is € 38,000. The BYD HAN and TANG pre-sale prices are € 72,000. These pre-sale prices apply to Germany as a reference for Europe and may differ from country to country. The three full-electric BYD vehicles are technologically advanced and well-suited to the e

Monrol Will Establish a Legal Entity and Manufacturing Facility in Germany28.9.2022 15:27:00 CEST | Press release

Following an ongoing assessment of its entire operation, Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) has decided to establish a legal entity and manufacturing facility in Germany. The new facility will focus on the manufacture of SPECT products and radiopharmaceutical products for radioligand therapy(*) such as Gallium-68 generator and n.c.a Lutetium-177. Developed by Monrol R&D teams, these products are widely used in the production of radiopharmaceuticals for cancer patients. The facility will also have a dedicated division for state-of-the art cGMP Contract Development and Manufacturing Organization (CDMO) services. Monrol plans to make the site a center of excellence for both radiopharmaceutical production and scientific and industry collaborative efforts to create innovations. The facility is expected to be up and running by 2026 at an estimated cost of around 30 million euros. (*) Targeted radioligand therapy is an innovative approach to cancer treatment that is considered to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom